Abstract

The addition of plant oils such as soybean oil (S) to a diet rich in saturated fatty acids is discussed as a possible route to prevent or diminish the development of metabolic disease. Here, we assessed whether a butterfat-rich diet fortified with S affects the development of early non-alcoholic steatohepatitis (NASH) and glucose intolerance. Female C57BL/6J mice were fed a standard-control diet (C); a fat-, fructose-, and cholesterol-rich diet (FFC, 25E% butterfat, 50% (wt./wt.) fructose, 0.16% (wt./wt.) cholesterol); or FFC supplemented with S (FFC + S, 21E% butterfat + 4E% S) for 13 weeks. Indicators of liver damage, inflammation, intestinal barrier function, and glucose metabolism were measured. Lipopolysaccharide (LPS)-challenged J774A.1 cells were incubated with linolenic and linoleic acids (ratio 1:7.1, equivalent to S). The development of early NASH and glucose intolerance was significantly attenuated in FFC + S–fed mice compared to FFC-fed mice associated with lower hepatic toll-like receptor-4 mRNA expression, while markers of intestinal barrier function were significantly higher than in C-fed mice. Linolenic and linoleic acid significantly attenuated LPS-induced formation of reactive nitrogen species and interleukin-1 beta mRNA expression in J774A.1 cells. Our results indicate that fortifying butterfat with S may attenuate the development of NASH and glucose intolerance in mice.

Highlights

  • Insulin resistance has been shown to be a key factor in the development of metabolic diseases including non-alcoholic fatty liver disease (NAFLD) [1]

  • The question of whether the addition of small amounts of soybean oil to the diet or fortifying butterfat with small amounts of soybean oil is associated with an increase of dietary intake of n3 fatty acids and an increase of the n3 to n6 ratio that may alter the development of NAFLD has not been studied in depth yet. Starting from this background, the aim of the present study was to assess whether replacing small amounts of butter fat with soybean oil (4E%) in an otherwise “unhealthy” butterfat, cholesterol, and fructose-rich diet affects the development of early signs of non-alcoholic steatohepatitis (NASH), a more progressed stage of NAFLD [19], in mice

  • In the present study, employing a pair-feeding liquid diet model allowing for an iso-caloric feeding of animals, we showed that fortifying a butterfat, fructose, and cholesterol-rich diet with soybean oil (4E%) in part attenuated the development of early NASH in mice

Read more

Summary

Introduction

Insulin resistance has been shown to be a key factor in the development of metabolic diseases including non-alcoholic fatty liver disease (NAFLD) [1]. The latter liver disease is often discussed as the hepatic manifestation of the metabolic syndrome [2]. In patients with type 2 diabetes, prevalence of NAFLD is even higher, ranging from 30% to 68% [5]. NAFLD is thought to be a rather slowly evolving disease with the development of liver phenotype in most patients ranging from 7 to 14 years per stage of liver fibrosis, and the window of opportunity for treatment seems rather large [6]. Despite intense research efforts in the last two decades, understanding of mechanisms underlying disease development is still limited, and therapeutic strategies up to now mainly focus on lifestyle interventions

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call